NeuroBo Pharmaceuticals Inc - Company Profile
Powered by
All the data and insights you need on NeuroBo Pharmaceuticals Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date NeuroBo Pharmaceuticals Inc Strategy Report
- Understand NeuroBo Pharmaceuticals Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on NeuroBo Pharmaceuticals Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
16 Sep 2022 | NeuroBo Pharma Files Registration Statement for Public Offering of Common Stock and Warrants | Equity Offering | - |
NeuroBo Pharmaceuticals Inc |
15 Sep 2022 | NeuroBo Pharma to Enter into Licensing Agreement with Dong-A ST | Licensing Agreement |
NeuroBo Pharmaceuticals Inc
|
Dong-A ST Co Ltd |
01 Oct 2021 | NeuroBo Pharma Raises USD14 Million in Private Placement of Shares and Warrants | Equity Offering | - |
NeuroBo Pharmaceuticals Inc |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer